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The foodborne enteric pathogen Campylobacter jejuni
decorates a variety of its cell-surface structures with
phosphoethanolamine (pEtN). Modifying lipid A with pEtN
promotes cationic antimicrobial peptide resistance, whereas
post-translationally modifying the flagellar rod protein FlgG
with pEtN promotes flagellar assembly and motility, which are
processes that are important for intestinal colonization. EptC,
the pEtN transferase required for all known pEtN cell-surface
modifications in C. jejuni, is a predicted inner-membrane
metalloenzyme with a five-helix N-terminal transmembrane
domain followed by a soluble sulfatase-like catalytic domain
in the periplasm. The atomic structure of the catalytic domain
of EptC (cEptC) was crystallized and solved to a resolution
of 2.40 A˚. cEptC adopts the // fold of the sulfatase protein
family and harbors a zinc-binding site. A phosphorylated
Thr266 residue was observed that was hypothesized to mimic
a covalent pEtN–enzyme intermediate. The requirement for
Thr266 as well as the nearby residues Asn308, Ser309, His358
and His440 was ascertained via in vivo activity assays on
mutant strains. The results establish a basis for the design of
pEtN transferase inhibitors.
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1. Introduction
Bacteria maintain a complex outer surface that gives rise to
a variety of biological functions. O-Linked phospho-form
modifications such as phosphoethanolamine (pEtN), phos-
phoglycerol and phosphocholine are found on a variety of
surface molecules, where they promote biosynthesis and
pathogenic functions in certain organisms. For example,
pEtN modifications are commonly associated with lipopoly-
saccharide/lipooligosaccharide (LPS/LOS) in Gram-negative
bacteria and have dedicated roles in the recognition and
evasion of host innate immune responses (Raetz et al., 2007;
Trent et al., 2006; Needham & Trent, 2013). More recently,
post-translational phospho-form modifications of the type IV
pili subunits of pathogenic Neisseria species and the flagellar
rod protein FlgG of Campylobacter jejuni have extended these
modifications to cell-surface proteins (Cullen & Trent, 2010;
Chamot-Rooke et al., 2011; Naessan et al., 2008).
Our laboratory previously identified the EptC protein, a
unique pEtN transferase in C. jejuni (Cullen & Trent, 2010).
C. jejuni is a Gram-negative enteric pathogen responsible, in
large part, for foodborne illness and bacteria-associated diar-
rhea in the United States and abroad (Scallan et al., 2011;
Havelaar et al., 2013). In terms of burden to health and cost,
campylobacteriosis ranks highest among foodborne infections
(Batz et al., 2012). Contracted by ingestion of contaminated
poultry and beef products, the disease is characterized by
gastrointestinal colonization followed by acute diarrhea. In
rare instances, secondary neurological symptoms may persist
in the form of the debilitating autoimmune disease Guillain–
Barre´ syndrome (Yuki & Hartung, 2012; Israeli et al., 2012).
C. jejuni has evolved a single pEtN transferase, EptC, that
modifies an array of cell-surface molecules, including the 1-
and 40-phosphoryl groups of lipid A (Cullen & Trent, 2010),
the first heptose residue of the inner-core oligosaccharide of
LOS (Cullen et al., 2013), residue Thr75 of the flagellar rod
protein FlgG (Cullen et al., 2012) and the N-linked glycans of
numerous glycoproteins (Scott et al., 2012) (Fig. 1). Conver-
sely, most mucosal pathogens appear to express several pEtN
transferases dedicated to the modification of one specific
target. For example, pathogenic Neisseria species produce the
enzymes LptA, Lpt3, Lpt6 and PptA that specifically transfer
pEtN to only one of the following: lipid A phosphoryl groups
(Cox et al., 2003), position 3 of LOS core heptose II (Mac-
kinnon et al., 2002; Wenzel et al., 2010), position 6 of LOS core
heptose II (Wright et al., 2004) or the major pilin protein PilE
(Naessan et al., 2008), respectively. Likewise, Escherichia coli
species possess at least three functional pEtN transferases
(EptA, EptB and CptA) that attach pEtN groups to specific
positions of LPS (Raetz et al., 2007). Owing to its uniquely
promiscuous nature, EptC is linked to multiple and distinct
biological functions in C. jejuni. Mutational studies demon-
strate that the loss of pEtN modifications causes a drastic
reduction in flagellar assembly/motility and a significantly
higher sensitivity to a range of cationic antimicrobial peptides
(Cullen & Trent, 2010; Cullen et
al., 2012). Most importantly, EptC
expression is required for proper
intestinal colonization of C. jejuni
in avian and mouse infection
models (Cullen et al., 2013).
The eptC gene (locus tag
Cj0256) is clustered in a family of
inner-membrane metalloenzymes
(COG2194) containing a five-
helix transmembrane domain and
a periplasmic catalytic domain
that is currently grouped in the
sulfatase family (Pfam00884;
Marchler-Bauer et al., 2013;
Fig. 1). Placement of the catalytic
domain dictates that pEtN modi-
fication occurs on the periplasmic
side of the inner membrane,
where EptC transfers head
groups from the phospholipid
phosphatidylethanolamine to
target molecules. Indeed, EptC
activity is not observed when
the enzyme is heterologously
expressed in a phosphatidyletha-
nolamine-deficient E. coli strain
(Cullen & Trent, 2010). To gain
insight into the structural basis of
enzyme function, we crystallized
and determined the atomic coor-
dinates of the catalytic domain of
EptC (cEptC) to a resolution of
2.40 A˚. Our structural data along
with mutational analysis of EptC
allowed us to identify zinc-ligand
residues, a putative nucleophile
and conserved active-site resi-
dues required for in vivo activity.
Moreover, we juxtaposed the
structures of cEptC and the
catalytic domains of the related
enzymes cLtaS (lipoteichoic acid
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Figure 1
Topology and biological functions of the C. jejuni phosphoethanolamine transferase EptC. (a) EptC is
predicted to be anchored to the inner membrane by a five-helix transmembrane domain, with its sulfatase-
like catalytic domain positioned in the periplasm. EptC transfers pEtN (red circles) from the head groups of
phosphatidylethanolamine onto the LOS core (gray rectangles) and phosphates (white circles) of lipid A
and Thr75 of FlgG proteins (blue boxes). Modifications of these C. jejuni surface structures with pEtN
promote flagellar assembly, motility, cationic antimicrobial peptide resistance and host intestinal
colonization (Cullen & Trent, 2010; Cullen et al., 2012, 2013). The organization of flagellar components
has previously been proposed (Chevance & Hughes, 2008). (b) Chemical structures of C. jejuni LOS and
phosphatidylethanolamine, with pEtN moieties in red. R1, -d-glucose; R2, outer core sugars; pEtN,
phosphoethanolamine; PtdEtN, phosphatidylethanolamine; DAG, diacylglycerol; LOS, lipooligosaccharide.
synthase from Bacillus subtilis and Staphylococcus aureus) and
cLptA (lipid A pEtN transferase from N. meningitidis). The
observed structural differences around the active sites of
cEptC and the lipid A-specific cLptA may provide clues to the
promiscuous nature of EptC.
2. Materials and methods
2.1. Strains and plasmid construction
The primers, plasmids and strains used in this study are
listed in Tables 1 and 2. Plasmid pETcEptC was constructed
for the overexpression of the catalytic domain of EptC
(cEptC; residues 203–512) fused to a Gly6His8 tag at the
C-terminus using the Polymerase Incomplete Primer Exten-
sion (PIPE) method (Klock & Lesley, 2009). Briefly, the
plasmid pET-28b(+) (Novagen) was linearized using the
V-PIPE primers 1 and 2 and subsequently gel-purified and
treated with the restriction enzyme DpnI (New England
Biolabs). The insert was colony PCR-amplified from C. jejuni
81-176 using the I-PIPE primers 3 and 4. The insert and
linearized vector were mixed, transformed into XL1-Blue
E. coli cells (Stratagene) and incubated overnight at 37C on
LB–agar plates containing 50 mg ml1 kanamycin.
EptC active-site mutants were constructed by site-directed
mutagenesis of plasmid pAtsAKO::cj0256-KanR (Cullen et al.,
2012) using primers 5–16 (Tables 1 and 2). The mutant alleles
were introduced into the eptC mutant strain C. jejuni 81-176
cj0256 as described previously (Cullen & Trent, 2010).
2.2. Expression, purification and crystallization of cEptC
E. coli BL21(DE3) cells expressing cEptC were cultured
in LB with 50 mg l1 kanamycin at 37C. Upon reaching an
OD600 of 0.6, the cultures were cooled to 18
C and induced
with 0.5 mM IPTG. After 18 h, the cells were pelleted, resus-
pended in lysis buffer [500 mM NaCl, 30 mM HEPES pH 7.5,
10%(v/v) glycerol] and sonicated. The lysate was clarified by
centrifugation and the soluble portion was poured over an
Ni–NTA column (Expedeon) equilibrated with lysis buffer.
The beads were washed with 15 mM imidazole in lysis buffer
and the bound protein was eluted with 150 mM imidazole in
lysis buffer. The eluate was further purified on a Superdex 200
gel-filtration column (GE Healthcare Life Sciences) equili-
brated with 150 mM NaCl, 10 mM HEPES pH 7.5. Seleno-
methionine (SeMet)-derivative protein was purified similarly
but was expressed in minimal medium with 50 mg l1 kana-
mycin supplemented with amino acids for methionine-
pathway inhibition (Doublie´, 1997).
SeMet-derivative and native proteins were concentrated to
30 mg ml1 in 25 mM NaCl, 10 mM HEPES pH 7.5. Crystals
were grown over the course of several days by sitting-drop
vapor diffusion at 22C by combining 4 ml protein solution
with 1 ml 200 mM diammonium phosphate, 15%(w/v) PEG
3350. SeMet-derived protein crystallized in space group
P212121, while the native protein crystallized in space group
C2221. Before flash-cooling in liquid nitrogen, the crystals
were cryoprotected in 200 mM diammonium phosphate,
16.5%(w/v) PEG 3350, 10%(v/v) glycerol for 10 s.
2.3. X-ray diffraction data collection, processing, phasing and
refinement
Native and SeMet-derivative data were collected on
Advanced Photon Source beamline 23-ID-B and processed
and scaled in HKL-2000 (Otwinowski & Minor, 1997)
(Table 3). Reflection intensities were converted to amplitudes
in TRUNCATE (French & Wilson, 1978) from the CCP4
software suite (Winn et al., 2011). A single-wavelength
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Table 1
Bacterial strains and plasmids.
Strains and plasmids Description Source
Escherichia coli
XL1-Blue General cloning strain, recA1 endA1 gyrA96thi-1 hsdR17 Stratagene
BL21(DE3) Protein-expression strain, F ompT gal dcm lon hsdSB(rB
 mB
) (DE3) Novagen
Campylobacter jejuni
81-176 Serotype HS: 23, 26 Cullen & Trent (2010)
81-176 A1 81-176 cj0256 clone1, CamR Cullen & Trent (2010)
81-176 B Complement strain, 81-176 cj0256 astA::cj0256, CamR, KanR Cullen & Trent (2010)
81-176 eptCT266A 81-176 cj0256 astA::cj0256T266A, Cam
R, KanR This study
81-176 eptCT266S 81-176 cj0256 astA::cj0256T266S, Cam
R, KanR This study
81-176 eptCN308A 81-176 cj0256 astA::cj0256N308, Cam
R, KanR This study
81-176 eptCS309A 81-176 cj0256 astA::cj0256S308A, Cam
R, KanR This study
81-176 eptCH358A 81-176 cj0256 astA::cj0256H358A, Cam
R, KanR This study
81-176 eptCH440A 81-176 cj0256 astA::cj0256H4440A, Cam
R, KanR This study
Plasmids
pET-28b(+) Expression vector containing a T7 promoter, AmpR Novagen
pETcEptC pET-28b(+)-derived expression plasmid used to express cEptC, AmpR This study
pAtsAKO::cj0256:KanR pGEM-atsAKO:KanR with cj0256 inserted Cullen & Trent (2010)
pETcEptCT266S T266S mutant derivative of pETcEptC, Amp
R This study
pAstAEptCT266A T266A mutant derivative of pAtsAKO::cj0256:Kan
R This study
pAstAEptCT266S T266S mutant derivative of pAtsAKO::cj0256:Kan
R This study
pAstAEptCN308A N308A mutant derivative of pAtsAKO::cj0256:Kan
R This study
pAstAEptCS309A S309A mutant derivative of pAtsAKO::cj0256:Kan
R This study
pAstAEptCH358A H358A mutant derivative of pAtsAKO::cj0256:Kan
R This study
pAstAEptCH4440A H440A mutant derivative of pAtsAKO::cj0256:Kan
R This study
anomalous dispersion (SAD) data set
was collected at the Se K edge ( =
0.9795 A˚) from one SeMet-derived
cEptC crystal that diffracted to 2.80 A˚
resolution. Initial phases were obtained
from AutoSol of the PHENIX software
suite (Adams et al., 2010), which iden-
tified 46 Se sites (30 were expected for
six monomers based on the sequence;
figure of merit = 0.329) in a P212121 unit
cell and generated six partial cEptC
monomers in the asymmetric unit
(Rwork/Rfree = 32.9/37.8%; map–model
correlation coefficient = 0.747). One of
the six monomers was subjected to
several cycles of refinement in Coot
(Emsley & Cowtan, 2004) and
REFMAC5 (Murshudov et al., 2011)
from CCP4 and was then employed as a
molecular-replacement search model to
phase the native data set in Phaser
(McCoy et al., 2007) from CCP4. One
native cEptC crystal diffracted to 2.50 A˚
resolution (Zn remote,  = 1.0332 A˚),
with a C2221 unit cell containing three
monomers. Iterative refinement was
carried out in Coot and phenix.refine of
PHENIX, with default NCS restraints
applied in the latter. Notably, for the
P212121 (SeMet-derivative) data set,
phenix.xtriage from PHENIX identified
an off-origin Patterson peak that was
30% of the origin peak, which
strongly indicates the presence of
translational pseudo-symmetry. No
pseudo-symmetry was detected for the
C2221 (native) data set.
The X-ray fluorescence of native
cEptC crystals was examined on
Advanced Light Source beamline 4.2.2
to identify the catalytic metal ion. A
data set was collected at the Zn K edge
( = 1.2680 A˚) from one crystal to
2.40 A˚ resolution; this was processed in
XDS (Kabsch, 2010) and scaled in
SCALA (Evans, 2006) from CCP4.
Data were truncated at a resolution at
which a compromise was reached between the hI/(I)i and
CC1/2 values (Karplus & Diederichs, 2012; Diederichs &
Karplus, 2013). Refinement was carried out as described
above. The two native data sets were merged in CAD to
generate an anomalous difference map in FFT (Read &
Schierbeek, 1988; both programs are from CCP4). The Zn K
edge data set was selected for deposition owing to less
apparent radiation damage to disulfides and zinc ions, as
evident in the Fo  Fc density (Supplementary Fig. S11; Weik
et al., 2000; Burmeister, 2000). The structure-factor amplitudes
and atomic coordinates of cEptC were deposited in the RCSB
Protein Data Bank as PDB entry 4tn0.
2.4. Protein mass spectrometry
LC-MS (AB Sciex 4000 QTrap hybrid triple quadrupole–
linear ion trap with Shimadzu Prominence analytical LC) was
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Figure 2
Structure of the C-terminal catalytic domain of the pEtN transferase EptC (cEptC) from C. jejuni.
(a) Secondary-structural features of a monomer. -Helices (green), -strands (red) and loops (gray)
are labeled as in Supplementary Fig. S3. Disulfides (yellow) and the phosphothreonine residue are
displayed in ball-and-stick representation, Zn2+ (purple) is displayed as a sphere and the N- and
C-termini are labeled. The dotted line indicates residues 213–215, for which there is no observable
electron density in monomer A. (b) Zinc-binding residues of the phosphoenzyme intermediate.
2Fo Fc map density (blue mesh) is contoured at 2.0 r.m.s.d. The metal ion was identified as Zn2+ by
anomalous diffraction (see Supplementary Fig. S7). Coordination bonds between side chains and
Zn2+ are indicated by dashed lines. All molecular images were generated in PyMOL (Schro¨dinger).
Table 2
Primers used in this study.
Underlined regions indicate introduced mutations.
1. F-VPIPEcEptC 50-ACCCCCGCCTCCCCTGGATTTGCCTTAAGTTTAGGATTTAA-30
2. R-VPIPEcEptC 50-AGGAGATATACCATGTTTAAAACTATAGCTAATGATGCTTATA-30
3. F-IPIPEcEptC 50-GGGGAGGCGGGGGTGGACACCACCACCACCACCACCACCACTGAGAT-30
4. R-IPIPEcEptC 50-CATGGTATATCTCCTTCTTAAAGTTAAACAAAATTATT-30
5. F-EptCT266S 50-ATTTTTCATCATGTGGAACAGCAAGCGCGGTAAGTTTGCCTTGTATGTTT-30
6. R-EptCT266S 50-AAACATACAAGGCAAACTTACCGCGCTTGCTGTTCCACATGATGAAAAAT-30
7. F-EptCT266A 50-ATTTTTCATCATGTGGAACAGCAGCGGCGGTAAGTTTGCCTTGTATGTTT-30
8. R-EptCT266A 50-AAACATACAAGGCAAACTTACCGCCGCTGCTGTTCCACATGATGAAAAAT-30
9. F-EptCN308A 50-GCATGGTTTGATAATGCATCTGGTGGTTGTAAA-30
10. R-EptCN308A 50-TTTACAACCACCAGATGCATTATCAAACCATGC-30
11. F-EptCS309A 50-TGGTTTGATAATAATGCAGGTGGTTGTAAAGGG-30
12. R-EptCS309A 50-CCCTTTACAACCACCTGCATTATTATCAAACCA-30
13. F-EptCH358A 50-CATTTGCAAGGTTCTGCAGGGCCAACTTATTAT-30
14. R-EptCH358A 50-ATAATAAGTTGGCCCTCGAGAACCTTGCAAATG-30
15. F-EptCH440A 50-AATGGTATTTATCTTGCAGGTATGCCTTATGCT-30
16. R-EptCH440A 50-AGCATAAGGCATACCTCGAAGATAAATACCATT-30
1 Supporting information has been deposited in the IUCr electronic archive
(Reference: MH5132).
employed in the collection of mass spectra. The protein
sample was eluted with a 0.5  50 mm PLRP-S column (8 mm,
4000 A˚; Michrom BioResources) with mobile phases A and B
(acetonitrile:water:formic acid:trifluoroacetic acid; A =
2:98:0.1:0.01; B = 90:10:0.1:0.01). A linear gradient of 5–65%
B was used to elute protein in 20 min at a flow rate of
20 ml min1. Automated acquisition of full-scan MS spectra
over the range 450–2000 Da was executed by Xcalibur
(Thermo Scientific). The acquired convoluted protein spectra
were deconvoluted by ProMass for Xcalibur 2.5.0 (Novatia) to
yield the [M + H]+ mass-to-charge values.
2.5. Motility assays
C. jejuni strains were initially grown from freezer stocks on
MH agar with 10 mg ml1 trimethoprim for 48 h at 37C under
microaerobic conditions (5% O2, 10%
CO2, 85% N2). Following the initial
growth, the strains were re-streaked and
grown under the same conditions. After
16 h, the strains were resuspended from
agar plates in MH broth and diluted to
an OD600 of 0.05, stab-inoculated into
semisolid MH motility medium
(containing 0.4% agar) and incubated
for 24 h at 37C under microaerobic
conditions. Relative motilities were
assessed from the diameter of the halos
of growth. Experiments were performed
in duplicate.
2.6. Polymyxin B resistance assay
Strains were grown in the same
manner as described for the motility
assays in x2.5 and swabbed onto MH
agar plates with 10 mg ml1 trimetho-
prim. Polymyxin B Etest strips
(bioMe´rieux) were applied to the
swabbed plates and incubated in
microaerobic conditions for 48 h at
37C before reading minimal inhibitory
concentrations (MICs). Experiments
were performed in duplicate.
3. Results and discussion
3.1. Overall structure of the catalytic
domain of EptC
In order to examine the structural
basis for enzyme function, we over-
expressed the catalytic domain of EptC
(cEptC; residues 203–512) fused to a
C-terminal Gly6His8 tag and determined
the X-ray crystal structure (Fig. 2).
After testing many gene truncations, we
obtained one that expressed sufficient
soluble protein suitable for crystallo-
graphy and confirmed the molecular weight of the gene
product (Supplementary Fig. S2). Including the His tag, cEptC
is composed of 325 residues and has a molecular weight of
36.7 kDa. The phases of cEptC were elucidated from a SAD
data set collected from a SeMet-derivative cEptC crystal that
diffracted to 2.80 A˚ resolution in space group P212121
(Table 3). Molecular replacement was carried out using one
monomer from the SeMet derivative as a search model for the
native data set. One native crystal diffracted to 2.40 A˚ reso-
lution in space group C2221. With the exception of residues
213–215 of chains A and C and residues 212–214 of chain B,
there is full coverage of the peptide backbone by the electron-
density map between the initiating Met202 and Pro512
(preceding the C-terminal His tag). Elevated B factors
(overall average = 49.8 A˚2), particularly for the lower half of
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Table 3
Data-collection and refinement statistics for cEptC.
Values in parentheses are for the outer shell.
Native, Zn K edge
Native, Zn remote
wavelength
SeMet derivative,
Se K edge
Data collection
Space group C2221 C2221 P212121
X-ray source Advanced Light
Source, 4.2.2
Advanced Photon
Source, 23-ID-B
Advanced Photon
Source, 23-ID-B
Wavelength (A˚) 1.2680 1.0332 0.9795
Temperature (K) 100 100 100
Unit-cell parameters (A˚, ) a = 121.9, b = 183.1,
c = 121.5,
 =  =  = 90.0
a = 122.5, b = 183.6,
c = 121.7,
 =  =  = 90.0
a = 119.1, b = 120.8,
c = 182.7,
 =  =  = 90.0
Resolution (A˚) 55–2.40 (2.46–2.40) 50–2.50 (2.54–2.50) 50–2.80 (2.85–2.80)
Rmerge† (%) 11.2 (99.6) 11.9 (95.5) 12.1 (82.9)
CC1/2‡ (%) 99.6 (67.4) 99.0 (85.4) 99.8 (75.6)
Average I/(I) 10.6 (1.5) 18.2 (2.8) 14.3 (2.0)
No. of observed reflections 392584 349675 729109
No. of unique reflections 53319 (3892) 47144 (2327) 119456 (5831)
Oscillation step () 0.2 1.0 1.0
No. of images 900 180 360
Exposure time per image (s) 0.4 1.0 1.0
Completeness (%) 99.7 (99.6) 99.9 (100) 99.7 (97.6)
Multiplicity 7.4 (7.4) 7.4 (7.2) 6.1 (4.9)
Monomers in asymmetric unit 3 3 6
Solvent content (%) 61.8 60.6 59.0
Matthews coefficient (A˚3 Da1) 3.22 3.12 3.00
Refinement
Resolution (A˚) 54.58–2.40 (2.43–2.40)
Rwork/Rfree§ (%) 21.5/25.6 (33.0/38.8)
No. of atoms
Overall 7411
Protein 7378
Ligand} 15
Water 18
Average B factors (A˚2)
Overall 49.8
Protein 49.8
Ligand} 44.3
Water 38.7
R.m.s.d., bond lengths (A˚) 0.009
R.m.s.d., bond angles () 1.28
Ramachandran favored (%) 96.8
Ramachandran allowed (%) 3.2
PDB code 4tn0
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the ith intensity measurement of reflection hkl
and hI(hkl)i is the average intensity for all reflections. ‡ CC1/2 is the correlation coefficient between two random half
data sets (Karplus & Diederichs, 2012; Diederichs & Karplus, 2013). § Rwork/Rfree =
P
hkl

jFobsj  jFcalcj

=
P
hkl jFobsj,
where Fobs and Fcalc are the observed and calculated structure factors, respectively. } Includes phosphoryl group and
Zn atoms.
the structure as arranged in Fig. 2, indicate increased mobility
in atomic positions: this may be owing to the absence of the
N-terminal transmembrane region of the enzyme or to the
dearth of crystal contacts in this region of each chain in the
asymmetric unit.
The cEptC catalytic domain assumes an // fold with a
six-stranded, central -sheet that is enveloped by a series of 11
-helices (Fig. 2), imparting an overall hemispherical shape.
-Strands and -helices are labeled 1–8 and 1–11,
respectively (Supplementary Fig. S3). The // fold is
common to proteins in the alkaline phosphatase superfamily
(pfam00245), which includes sulfatases. Enzymes of this family
cleave ester bonds such as sulfoester and phosphoester
linkages, a reaction that is likely to be required for EptC
function. A zinc-binding site, identified by anomalous
diffraction, is located on the flat surface of the hemisphere and
is fairly exposed to solvent (Supplementary Fig. S4a). As the
putative nucleophile Thr266 resides at the N-terminus of 2,
a helical dipole may help to stabilize a nucleophilic alkoxide
form of its side chain. A phosphoryl group was found attached
to Thr266 to form phosphothreonine (Supplementary Fig. S5),
which we speculate mimics a pEtN–enzyme intermediate.
Consistent with the location of cEptC in the oxidizing envir-
onment of the periplasm, three disulfide bonds are present
(Fig. 2): between residues Cys262 and Cys272, Cys312 and
Cys316, and Cys377 and Cys385. Cys272 is located on the
nucleophilic helix, while Cys262 is on the loop extending from
the N-terminus of that helix. Cys312 resides on a loop near the
nucleophilic Thr266 and, with Cys316, may play a role in
properly positioning an active-site loop, as discussed below. In
contrast, the Cys377–Cys385 pair is more distant from the
active site.
3.2. Comparison of cEptC with known phospho-form
transferase structures
Phospho-form transferase enzymes transfer phospho-form
structures such as pEtN and phosphoglycerol to the hydroxyl
and phosphoryl groups of target molecules to promote their
biological functions. In addition to the cEptC structure
presented here, the structures of two other phospho-form
transferase proteins have previously been reported: the cata-
lytic domain of S. aureus (Lu et al., 2009) and B. subtilis
(Schirner et al., 2009) lipoteichoic acid synthase LtaS (cLtaS;
PDB entries 2w5s and 2w8d), and most recently the catalytic
domain of the lipid A pEtN transferase LptA (cLptA; PDB
entry 4kay) of N. meningitidis (Wanty et al., 2013). LtaS, a
phosphoglycerol transferase that is distantly related to EptC,
synthesizes the polyphosphoglycerol backbone structure of
lipoteichoic acid in Gram-positive bacteria. LptA is func-
tionally similar to EptC in that it adds pEtN to the phosphoryl
groups of lipid A; however, LptA displays specificity for lipid
A alone, while EptC has multiple molecular targets. Like
cEptC, the C-terminal domains cLptA and cLtaS adopt the
// alkaline phosphatase-like fold (Fig. 3), which is fused
to a predicted N-terminal five-helix transmembrane domain.
Together, these three proteins represent a class of bacterial
membrane-associated, biosynthetic enzymes with similar
activities (phospho-form transfer), although the products and
biological outcomes are widely varied.
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Figure 3
Overall structures of the pEtN transferases cEptC and cLptA and the B. subtilis lipoteichoic acid synthase cLtaS. (a) cEptC (green), with
phosphothreonine and disulfides shown in ball-and-stick representation and the Zn2+ ion as a purple sphere. (b) cLptA (PDB entry 4kay; cyan), with
phosphothreonine and disulfides shown in ball-and-stick representation and Zn2+ ions as purple spheres. Structural insertions found in cLptA, but not
cEptC, are colored yellow. cLptA and cEptC superpose with a C r.m.s.d. of 0.59 A˚ over 211 residues. (c) B. subtilis cLtaS (PDB entry 2w8d; orange),
with phosphothreonine shown in ball-and-stick representation and the Mg2+ ion as a green sphere. Structural features unique to cLtaS are colored blue.
cLtaS and cEptC superpose with a C r.m.s.d. of 3.74 A˚ over 216 residues.
The cEptC and cLtaS structures share a number of common
core -strands and -helices that align with a C r.m.s.d. of
3.74 A˚ over 216 residues (Figs. 3a and 3c; Supplementary Figs.
S4a and S4c). The main differences between the two structures
are the positioning of the loop regions and the presence of
insertions that are only observed in cLtaS. For instance, cLtaS
has an extra 79-residue C-terminal region composed of a five-
stranded -sheet and a long -helix. Additionally, a helix–
loop–helix structure spanning residues 477–500 corresponds
to a loop region between 6 and 7 of cEptC. Interestingly,
this loop in the cEptC structure is oriented towards the active
site and positions His440 N"2 within hydrogen-bonding
distance (3.0 A˚) of a phosphoryl O atom of phospho-Thr266
(Figs. 3a and 4a). In contrast, the helix–loop–helix structure of
cLtaS is oriented in the opposite direction, causing this region
of the active site to be more open in cLtaS (Figs. 3c and 4c).
Finally, LtaS contains an additional helix positioned in a loop
region between the corresponding 2 and 3 of cEptC
(Figs. 4a and 4c). Side chains on the N-terminal end of this
helix and the preceding loop have been shown to bind phos-
phoglycerol in S. aureus cLtaS (PDB entry 2w5s; Lu et al.,
2009). The major structural differences observed between
cEptC and cLtaS presumably contribute to their distinct
enzyme–substrate interactions.
The cEptC and cLptA structures are strikingly similar, as
noted by their 44% amino-acid sequence identity and
observed C r.m.s.d. of 0.59 A˚ over 211 residues (Figs. 3a and
3b; Supplementary Figs. S4a and S4b). The disulfide-bonding
pattern of cLptA is identical to that of cEptC, with the
exception of two additional disulfides between residues
Cys348–Cys353 and Cys499–Cys540 in cLptA. Interestingly,
these extra disulfides occur in the only regions that differ
significantly from cEptC. Cys499 is part of an -helix that
corresponds to 10 of cEptC. Also, cLptA contains an extra
eight-residue -helix between the corresponding 8 and 10
of cEptC that, together with the Cys499–Cys540 disulfide,
causes 10 to take on a different pitch than observed in cEptC.
The second additional disulfide between Cys348 and Cys353 of
cLptA is in a loop spanning residues 339–354 adjacent to the
active site. Curiously, this loop is significantly shorter in the
cEptC structure (residues 325–329), despite the similarity in
sequence and structure to cLptA around this region. It is
possible that this extended loop plays a part in substrate
specificity in cLptA, and its absence from the cEptC structure
may allow the entry of more diverse molecular targets.
3.3. Active-site architecture of cEptC
The cEptC active site contains a tetrahedrally coordinated
zinc ion and a putative nucleophilic threonine, Thr266, cova-
lently bound to a phosphoryl group to form phosphothreonine
(Fig. 4a). We reason that phospho-Thr266 mimics an enzyme
reaction intermediate representing the first step in a two-step
transferase reaction. Phosphothreonine was also observed in
the cLptA (Wanty et al., 2013) and B. subtilis cLtaS (Schirner
et al., 2009) structures (Figs. 3b and 3c).
Coordinated divalent metals are important cofactors for
enzymes in the alkaline phosphatase protein superfamily, as
they are implicated in substrate binding and catalysis (Kim &
Wyckoff, 1991; O’Brien & Herschlag, 2001; Stec et al., 2000).
The cEptC zinc ion is tetrahedrally coordinated by residues
Glu227, phospho-Thr266, Asp427 and His428. By sequence
alignment and structural comparison, these residues are highly
conserved in the characterized phospho-form transferase
members of COG2194 (includes pEtN transferases) and
COG1368 (includes phosphoglycerol transferases) (Supple-
mentary Fig. S6). The orientation of these residues is well
conserved between cEptC, cLptA and cLtaS, with r.m.s.d.
values of 0.26 A˚ over 30 atoms and 0.18 A˚ over 21 atoms when
comparing cEptC with cLptA and B. subtilis cLtaS, respec-
tively (Supplementary Fig. S7). Of the two cLtaS structures
solved, one was shown to bind a magnesium ion (Schirner
et al., 2009) and the other a manganese ion (Lu et al., 2009)
(compare Supplementary Fig. S7c and Fig. 4c). The cLptA
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Figure 4
Juxtaposed active sites of (a) cEptC, (b) cLptA (PDB entry 4kay) and (c) S. aureus cLtaS (PDB entry 2w5s). Active-site architectures and zinc-binding
residues are conserved between cEptC and cLptA (Supplementary Fig. S6), although only one Zn2+ ion associates with cEptC in crystallo. His358/His383
and metal-ligand residues of cEptC and cLptA are also conserved in cLtaS. Side chains on an active-site loop/helix of cLtaS, corresponding to a loop
between 2 and 3 of cEptC, bind phosphoglycerol (PG, white C atoms; Lu et al., 2009). In cEptC and cLptA, this loop contains Asn308/Asp324 and
Ser309/Ser325, which may contribute to substrate binding. Notably, Thr266, His358, His440, Asn308 and Ser309 mutant strains of eptC in C. jejuni
displayed polymyxin B sensitivity and a severe loss of motility (Figs. 5 and 6).
structure, on the other hand, contains two zinc ions (Fig. 4b),
reminiscent of the E. coli alkaline phosphatase PhoA (PDB
entry 1ed8; Wanty et al., 2013; Stec et al., 2000). It is worth
noting that only one zinc ion, corresponding to the zinc and
magnesium/manganese ions of cEptC and cLtaS, was observed
unless the cLptA crystals were soaked with 1 mM zinc sulfate.
Nevertheless, the zinc-coordinating residues of cLptA super-
impose well onto corresponding residues of alkaline phos-
phatase (Wanty et al., 2013) and, importantly, most of these
residues are conserved in cEptC, cLtaS and several diverse
pEtN transferases (Supplementary Fig. S6). More specifically,
the first-zinc ligand residues Glu227/240, Thr266/280, Asp427/
452 and His428/453 of cEptC/cLptA directly correspond to
Asp51, Ser102, Asp369 and His370 of alkaline phosphatase,
and the second-zinc ligand residues His358/383 and His440/
465 correspond to Asp327 and His412 of alkaline phosphatase.
Another second-zinc ligand residue, His331, is found in
alkaline phosphatase but not in cLptA or cEptC. Additional
studies will be necessary to determine the extent of this
similarity, as well as the capacity of cEptC to bind multiple
zinc ions.
3.4. Mutational characterization of conserved cEptC
active-site residues
Based on a sequence alignment of COG2194 members
(Supplementary Fig. S6), we identified conserved amino-acid
residues that correspond to the cEptC active-site residues
Thr266, Asn308, Ser309, His358 and His440 (Fig. 4a). In order
to assess the functional requirement of these active-site resi-
dues, we prepared mutant strains of C. jejuni 81-176 carrying
point mutations for each residue, as described in x2.1. We
previously established that a functional eptC allele is required
for pEtN modification of the flagellar rod protein FlgG and
lipid A in C. jejuni (Cullen & Trent, 2010; Cullen et al., 2012).
These modifications are unequivocally responsible for proper
flagellar assembly, motility and resistance to polymyxin B. To
this end, we monitored the in vivo activity of mutant EptC
enzymes by comparing the minimal inhibitory concentration
(MIC) of polymyxin B and the halo-of-growth diameter in
motility assays. All of the active-site mutants were significantly
less resistant to polymyxin B when compared with the parent
strain 81-176 (Fig. 5). The S309A mutant displayed a sixfold
decrease in polymyxin B resistance, while the remaining
active-site mutants and the eptC null mutant displayed a
15.8-fold decrease. All of the mutants were also significantly
impaired with respect to motility (Fig. 6). Interestingly, the
N308A, S309A, H440A, H358A and T266S mutants displayed
the most severe motility defects, while the T266A mutant was
comparable to the eptC null strain after 24 h of growth. It
was previously determined that roughly 10% of the eptC
mutant population produces visible flagella (Cullen & Trent,
2010), giving rise to partial recovery of motility as demon-
strated in Fig. 6 (compare 81-176, eptC and the nonmotile
strain H358A as a reference). The more pronounced motility
defects observed for most of the active-site mutants presented
here may reflect the fact that these strains express inactive
protein that precludes partial recovery of motility via
unknown mechanisms.
Taken together, the loss of motility and polymyxin B
resistance suggest a crucial role for Thr266, Asn308, Ser309,
His358 and His440 in EptC function. Notably, Asn308 O1,
Asn308 N2 and Ser309 O are 5.5, 6.7 and 6.4 A˚ from
phospho-Thr266 O3P (chain A), respectively, which places
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Figure 5
Minimal inhibitory concentrations (MICs) of polymyxin B for C. jejuni
EptC active-site mutants. Parent strain (81-176), eptC null mutant
(eptC), complemented eptC strain carrying a copy of the native eptC
allele (eptC/eptC+) and mutant strains carrying eptC alleles with single
amino-acid mutations (T266A, T266S, N308A, S309A, H358A and
H440A) were swabbed onto MH agar plates with 10 mg ml1 trimetho-
prim and subjected to the polymyxin B Etest strip assay. MICs were
recorded after 48 h. The numbers above each bar in the graph indicate
polymyxin B MICs in mg ml1.
Figure 6
EptC active-site mutant motility assays. Parent strain (81-176), eptC null
mutant (eptC), complemented eptC strain (eptC/eptC+) and strains
carrying eptC active-site mutant alleles (T266A, T266S, N308A, S309A,
H358A and H440A) were stab-inoculated into semisolid MH motility
medium and incubated under microaerobic conditions. To assess relative
motility, bacterial growth diameters were visually compared 24 h post-
inoculation.
them within hydrogen-bonding distance of a pEtN moiety
covalently linked to Thr266.
To further explore the phosphorylation of Thr266, we
expressed and purified soluble cEptC protein that contained a
T266S mutation and investigated the presence of phospho-
serine. The molecular weights of native and mutant cEptC
proteins were determined by mass spectrometry in the positive
mode with an accuracy of 5 u. The deconvoluted cEptC
spectrum showed a major peak at 36 750 u, consistent with the
calculated [M + H]+ of native cEptC (Supplementary Fig.
S2a). As expected, another major peak was observed with a
mass shift of +80 u, demonstrating the presence of phospho-
threonine as observed in the cEptC crystal structure. Corre-
sponding peaks with masses of 36 477 and 36 556 u suggest
the loss of two histidine residues (273 u), likely owing to
proteolysis of the disordered His tag during expression and
purification. In contrast to native cEptC, the T266S mutant
spectrum showed one major peak at 36 740 u, consistent with
unmodified protein, and a corresponding minor peak indi-
cating the loss of two histidine residues (272 u; Supple-
mentary Fig. S2c). Taken together, these results suggest that
serine cannot replace threonine in EptC catalysis and that the
phosphothreonine observed in the cEptC crystal structure and
mass spectrum is indeed most likely owing to the catalytic
activity of cEptC.
4. Conclusion
We present the structure of the catalytic domain of EptC,
the only known phosphoethanolamine transferase from the
Gram-negative pathogen C. jejuni. Despite the wide array of
molecules modified by EptC, our structure displays extensive
similarities to the lipid A-specific cLptA of N. meningitis and
fewer similarities to the distantly related phosphoglycerol-
specific cLtaS of B. subtilis and S. aureus. Like cLptA and
cLtaS, cEptC assumes an // fold that coordinates a divalent
metal ion and possesses a nucleophilic threonine modified
with a phosphoryl group. We suggest that this residue mimics a
covalent phosphoethanolamine–enzyme intermediate. Given
the similarities among the active sites of these phospho-form
transferases and alkaline phosphatase, the enzymes are
expected to share mechanistic features. C. jejuni strains with
point mutations at EptC residues Thr266, Asn308, Ser309,
His358 and His440 suffered polymyxin B sensitivity and severe
loss of motility, indicating that the active sites of EptC and
other lipid A phosphoethanolamine transferases may be
effective targets for drug design. C. jejuni has increasingly
been recognized as a major causative agent of foodborne
illness worldwide. Our analysis of the catalytic domain of
EptC augments the structural characterization of phospho-
ethanolamine transferases and sets the foundation for the
development of inhibitory drugs to combat infections by
C. jejuni and related bacteria.
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